FDA.reportPublic FDA data

6-O-palmitoylascorbic acid 12 MG / alpha-tocopherol acetate 75 UNT / levocarnitine 250 MG / ubidecarenone 30 MG Oral Capsule

RxCUI
1088443
RxNorm name
6-O-palmitoylascorbic acid 12 MG / alpha-tocopherol acetate 75 UNT / levocarnitine 250 MG / ubidecarenone 30 MG Oral Capsule
Display name
O-palmitoylascorbic acid/Alpha tocopherol/levOCARNitine/Ubidecarenone (Oral Pill)
Full name
6-O-palmitoylascorbic acid 12 MG / alpha-tocopherol acetate 75 UNT / levocarnitine 250 MG / ubidecarenone 30 MG Oral Capsule
Term type
SCD
Status
Active
Strength
12-75-250-30 var units
Dose form
Cap
Route
Oral Pill
Updated
2026-06-06 07:12:43

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032011
Active start
032011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
6-O-palmitoylascorbic acid12 MG / 1 EACH6-O-palmitoylascorbic acid6-O-palmitoylascorbic acid
ubidecarenone30 MG / 1 EACHubidecarenoneubidecarenone
alpha-tocopherol acetate75 UNT / 1 EACHalpha tocopherolalpha-tocopherol acetate
levocarnitine250 MG / 1 EACHlevocarnitinelevocarnitine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
6-O-palmitoylascorbic acid1088438
ubidecarenone21406
alpha tocopherol237099
levocarnitine42955

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STR6-O-palmitoylascorbic acid 12 MG / alpha-tocopherol acetate 75 UNT / levOCARNitine 250 MG / ubidecarenone 30 MG Oral CapsuleNAMES
RxNorm Name6-O-palmitoylascorbic acid 12 MG / alpha-tocopherol acetate 75 UNT / levocarnitine 250 MG / ubidecarenone 30 MG Oral CapsuleNAMES
TTYSCDATTRIBUTES
RxCUI1088443CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA16AAAmino acids and derivativesATC1-4levocarnitine
ATCC01EBOther cardiac preparationsATC1-4ubidecarenone
FDASPLD002331CarnitineCHEMhas_chemical_structurelevocarnitine
FDASPLN0000175903Carnitine AnalogEPChas_epclevocarnitine
MEDRTD024502alpha-TocopherolCHEMhas_ingredientalpha tocopherol
MEDRTD024502alpha-TocopherolCHEMhas_ingredientalpha-tocopherol acetate
MEDRTD001205Ascorbic AcidCHEMhas_ingredient6-O-palmitoylascorbic acid
MEDRTD002331CarnitineCHEMhas_ingredientlevocarnitine
MEDRTD014451UbiquinoneCHEMhas_ingredientubidecarenone
MEDRTD000544Alzheimer DiseaseDISEASEmay_treatalpha-tocopherol acetate
MEDRTD000544Alzheimer DiseaseDISEASEmay_preventalpha tocopherol
MEDRTD000544Alzheimer DiseaseDISEASEmay_preventalpha-tocopherol acetate
MEDRTD000743Anemia, HemolyticDISEASEmay_preventalpha tocopherol
MEDRTD000743Anemia, HemolyticDISEASEmay_treatalpha-tocopherol acetate
MEDRTD000743Anemia, HemolyticDISEASEmay_preventalpha-tocopherol acetate
MEDRTD000787Angina PectorisDISEASEmay_treatubidecarenone
MEDRTD001997Bronchopulmonary DysplasiaDISEASEmay_preventalpha-tocopherol acetate
MEDRTD001997Bronchopulmonary DysplasiaDISEASEmay_preventalpha tocopherol
MEDRTD003677Deficiency DiseasesDISEASEmay_treatlevocarnitine
MEDRTD004342Drug HypersensitivityDISEASEci_withalpha-tocopherol acetate
MEDRTD004342Drug HypersensitivityDISEASEci_withubidecarenone
MEDRTD004342Drug HypersensitivityDISEASEci_withlevocarnitine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventubidecarenone
MEDRTD004409Dyskinesia, Drug-InducedDISEASEmay_preventalpha-tocopherol acetate
MEDRTD004409Dyskinesia, Drug-InducedDISEASEmay_treatalpha-tocopherol acetate
MEDRTD004409Dyskinesia, Drug-InducedDISEASEmay_preventalpha tocopherol
MEDRTD015673Fatigue Syndrome, ChronicDISEASEmay_treatubidecarenone
MEDRTD006333Heart FailureDISEASEmay_treatubidecarenone
MEDRTD006816Huntington DiseaseDISEASEmay_treatubidecarenone
MEDRTD006949HyperlipidemiasDISEASEmay_treatubidecarenone
MEDRTD006973HypertensionDISEASEmay_treatubidecarenone
MEDRTD014811Vitamin E DeficiencyDISEASEmay_preventalpha-tocopherol acetate
MEDRTD014811Vitamin E DeficiencyDISEASEmay_treatalpha tocopherol
MEDRTD014811Vitamin E DeficiencyDISEASEmay_treatalpha-tocopherol acetate
MEDRTN0000000142Biological Macromolecular ActivityMOAhas_moalevocarnitine
MEDRTN0000000163Enzyme InteractionsMOAhas_moaubidecarenone
MEDRTN0000000170Free Radical Scavenging ActivityMOAhas_moaalpha tocopherol
MEDRTN0000000170Free Radical Scavenging ActivityMOAhas_moaalpha-tocopherol acetate
MEDRTN0000008337Cellular Activity AlterationPEhas_pelevocarnitine
MEDRTN0000009934Decreased Vitamin Uptake and ModificationPEhas_pealpha tocopherol
MEDRTN0000009934Decreased Vitamin Uptake and ModificationPEhas_pealpha-tocopherol acetate
MEDRTN0000009925Unknown Physiological EffectPEhas_peubidecarenone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH12 MG / 75 UNT / 250 MG / 30 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESRxCUI1088443
NAMESRXNAV_STR6-O-palmitoylascorbic acid 12 MG / alpha-tocopherol acetate 75 UNT / levOCARNitine 250 MG / ubidecarenone 30 MG Oral Capsule
NAMESRxNorm Name6-O-palmitoylascorbic acid 12 MG / alpha-tocopherol acetate 75 UNT / levocarnitine 250 MG / ubidecarenone 30 MG Oral Capsule
NAMESTallman Synonym6-O-palmitoylascorbic acid 12 MG / alpha-tocopherol acetate 75 UNT / levOCARNitine 250 MG / ubidecarenone 30 MG Oral Capsule
SOURCESSourceNational Drug Data File Plus Source Vocabulary